Latest news with #SubsequentOffering
Yahoo
2 days ago
- Business
- Yahoo
IDEX Biometrics ASA: Final result of the Subsequent Offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice from IDEX Biometrics ASA (the "Company") on 21 May 2025 regarding the commencement of the subscription period (the "Subscription Period") in the subsequent offering (the "Subsequent Offering") consisting of up to 600,000,000 new shares (the "Offer Shares") in the Company at a subscription price of NOK 0.01 per share ("Offer Price"). The Subscription Period commenced on 22 May 2025 and expired on 5 June 2025. By the end of the Subscription Period, the Subsequent Offering was 8x oversubscribed. Pursuant to the resolution by the Extraordinary General Meeting dated 11 April 2025, the Company's board of directors has today resolved to allocate and issue a total of 600,000,000 Offer Shares at the Offer Price in accordance with the allocation criteria set out in the prospectus dated 21 May 2025, raising gross proceeds of NOK 6 million. Investors that are allocated Offer Shares can access information on the number of Offer Shares allocated to them through VPS on or about 6 June 2025. The due date for payment of the Offer Shares is on 11 June 2025. Subject to duly and timely payment of the Offer Shares, the share capital increase pertaining to the Subsequent Offering is expected to be registered in the Norwegian Register of Business Enterprises ('NRBE') on or about 13 June 2025. Following registration of the share capital increase associated with the Subsequent Offering in the NRBE, the Company's share capital will be NOK 44,316,309.99 consisting of 4,431,630,999 shares, each having a par value of NOK 0.01. The Offer Shares will be delivered to the VPS accounts of the subscribers shortly thereafter, expected on or about 13 June 2025. A separate announcement will be made when the share capital increase has been registered. The Offer Shares will have equal rights and rank pari passu with the Company's other shares. Arctic Securities AS is acting as manager in connection with the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS is acting as the Company's legal advisor. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ IMPORTANT NOTICE This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities of the Company. Copies of this announcement are not being made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and accordingly may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any part of the offering in the United States or to conduct a public offering of securities in the United States. In any EEA Member State, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The "Prospectus Regulation" means Regulation (EU) 2017/1129, as amended (together with any applicable implementing measures) in any Member State. This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only for relevant persons and will be engaged in only with relevant persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. The issue, subscription or purchase of shares in the Company is subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Managers assume any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "strategy", "intends", "estimate", "will", "may", "continue", "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believe that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond their control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not make any guarantee that the assumptions underlying the forward-looking statements in this announcement are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this announcement or any obligation to update or revise the statements in this announcement to reflect subsequent events. You should not place undue reliance on the forward-looking statements in this announcement. The information, opinions and forward-looking statements contained in this announcement speak only as at its date and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this announcement. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions. This announcement is an advertisement and is not a prospectus for the purposes of the Prospectus Regulation as implemented in any Member State. About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 6 June 2025 at 17:20 CET on behalf of IDEX Biometrics ASA. The information is published in accordance with section 5-8 of the Norwegian Securities Trading Act (STA) and released in accordance with section 5-12 of the in to access your portfolio
Yahoo
21-05-2025
- Business
- Yahoo
IDEX Biometrics ASA: Approved prospectus
Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion' and 'Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000. The listing of the Debt Conversion Shares, the Subsequent Offering and the listing of the Offer Shares remain subject to approval of a prospectus ("Prospectus") by the Financial Supervisory Authority of Norway ("FSA"), and the subsequent publication of such Prospectus by the Company. Further, the future listing of shares that may be issued by the Company upon conversion of the Convertible Bond (the conversion price currently being NOK 0.065, but which conversion price is subject to customary adjustment provisions) also remains subject to approval and publication of a Prospectus. The FSA has today approved the Prospectus. As a result of the above, the subscription period for the Subsequent Offering starts on 22 May 2025 and expires on 5 June 2025 at 16:30 CET. For further information on the Subsequent Offering, please refer to the Prospectus. Further, by reason of the approval and publication of the Prospectus, the Debt Conversion Shares will be transferred to the Company's ordinary ISIN and be admitted to trading on Oslo Børs. The Prospectus is enclosed with this announcement. It will also be available in electronic format at . Printed copies of the Prospectus may be obtained free of charge at the office of IDEX Biometrics ASA, Dronning Eufemias gate 16, NO-0191 Oslo, Norway, telephone +47 6783 9119 or by e-mail: companysecretary@ Arctic Securities AS acts as financial advisor and bookrunner in connection with the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS acts as the Company's legal advisor. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 21 May 2025 at 08:45 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12. Attachment 2025-05-21 Prospectus incl subscription form- IDEX Biometrics ASAError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
IDEX Biometrics ASA: Approved prospectus
Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion' and 'Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000. The listing of the Debt Conversion Shares, the Subsequent Offering and the listing of the Offer Shares remain subject to approval of a prospectus ("Prospectus") by the Financial Supervisory Authority of Norway ("FSA"), and the subsequent publication of such Prospectus by the Company. Further, the future listing of shares that may be issued by the Company upon conversion of the Convertible Bond (the conversion price currently being NOK 0.065, but which conversion price is subject to customary adjustment provisions) also remains subject to approval and publication of a Prospectus. The FSA has today approved the Prospectus. As a result of the above, the subscription period for the Subsequent Offering starts on 22 May 2025 and expires on 5 June 2025 at 16:30 CET. For further information on the Subsequent Offering, please refer to the Prospectus. Further, by reason of the approval and publication of the Prospectus, the Debt Conversion Shares will be transferred to the Company's ordinary ISIN and be admitted to trading on Oslo Børs. The Prospectus is enclosed with this announcement. It will also be available in electronic format at . Printed copies of the Prospectus may be obtained free of charge at the office of IDEX Biometrics ASA, Dronning Eufemias gate 16, NO-0191 Oslo, Norway, telephone +47 6783 9119 or by e-mail: companysecretary@ Arctic Securities AS acts as financial advisor and bookrunner in connection with the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS acts as the Company's legal advisor. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 21 May 2025 at 08:45 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12. Attachment 2025-05-21 Prospectus incl subscription form- IDEX Biometrics ASA
